Pharmaceutical Executive-06-01-2021

Betting on Its Base in Virology

June 09, 2021

Features

41

6

How Gilead readied remdesivir for the COVID challenge.

Scientific Rigor, Urgent Action

June 09, 2021

Features

41

6

Inside Regeneron’s monoclonal antibody development to treat COVID.

Meeting the Crisis Head-On

June 09, 2021

Features

41

6

Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.

Innovation in High Gear

June 09, 2021

Features

41

6

Thrust into a commercial-stage company in just months, Moderna moves full steam ahead.

Bonds Old and New to the Rescue

June 09, 2021

Features

41

6

College roommates, industry partnerships help bring Pfizer vaccine to fruition.

2021 Pharm Exec 50

June 09, 2021

Features

41

6

Pharm Exec’s latest listing of the top global biopharma sales producers captures the critical business and public health balancing act that was required in the Year of COVID—reinforcing the staying power of building brand value while championing medical innovation.

A Steward of Science

June 09, 2021

Executive Profile

41

6

Building on a lifelong passion for biomedical research, and then its application in policy and health equity as a leader in various interconnected settings, Michelle McMurry-Heath, president and CEO of BIO, is uniquely positioned as a “translator” for science and social advocacy—and speaking stakeholders to action.

A Strong Healthcare Ecosystem

June 09, 2021

Chairman’s Letter

41

6

A letter on the June 2021 issue of Pharm Exec from Chairman and Founder of MJH Life Sciences, Mike Hennessy Sr.